Молодежный инновационный вестникМолодежный инновационный вестник2415-7805Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации7120Conference ProceedingsDRUGS OF CHOICE FOR THE TREATMENT OF OUT-OF-HOSPITAL BACTERIAL PNEUMONIA IN CHILDRENYanKseniya Sergeevnaxena.yan@mail.ruhttps://orcid.org/0000-0002-7651-3748NesterovaAnastasiya Vladimirovnaanvnesterova@mail.ruhttps://orcid.org/0000-0002-5885-349030062022112322352901202221022022Copyright © 2022, Yan K.S., Nesterova A.V.2022<p>Relevance. Diseases of the respiratory system occupy a leading place in their prevalence among children of various age categories from year to year. According to statistical materials provided by the Ministry of Health of the Russian Federation, 101,956 cases of respiratory pathologies were noted in 2020, which is 76% of the total number of registered diseases in patients with a diagnosis established for the first time in their lives. Despite the extremely wide range of antibacterial drugs on the modern pharmaceutical market, the chosen treatment strategy does not always lead to the achievement of the goal. For example, community-acquired pneumonia at the moment still remains one of the main causes leading to death among children at an early age everywhere, which indicates the need for a detailed examination of the drugs most commonly used in pediatric practice, identifying aspects of effectiveness or, conversely, their ineffective use.<br />Purpose. To study the properties of the drugs of choice for the treatment of community-acquired pneumonia of bacterial etiology in children, the range of antibiotics in pharmacies in Voronezh, to identify the demand for them and the main reasons explaining the lack of drugs.<br />Materials and methods. The study was conducted on the basis of pharmacies of private and state ownership in Voronezh during December<a href="https://vk.com/away.php?utf=1to=http%3A%2F%2F2021.At" target="_blank" rel="noopener">2021.At</a>the first stage of the study, employees of pharmacy organizations were offered a list of drugs specified in the clinical recommendations for the treatment of pneumonia, with a request to indicate the drugs available. At the second stage, information was collected on the reasons for the lack of antibiotics, as well as an analysis of the information received.<br />Results. During the consideration of the availability of drugs of interest to us and the demand for them, it was found out that the choice of the drug depends more on the etiology of pneumonia and the severity of the child's condition. In the treatment of typical and atypical community-acquired pneumonia, the main emphasis is placed on such groups of antibacterial drugs as aminopenicillins, macrolides, cephalosporins, fluoroquinolones. Depending on the social status and material capabilities of the family, the pharmacy assortment includes drugs at a cost from the most expensive to cheaper analogues of the original generic drugs, identical to the original in composition and therapeutic effect, but produced by other manufacturers.<br />Conclusion. Rational antibiotic therapy underlies the therapy of typical and atypical community-acquired pneumonia of bacterial etiology. The correct approach in choosing medicines, taking into account possible side effects, the risk of resistance of the pathogen to a particular group of antibiotics allows the dynamics of the disease to acquire a positive character.</p>community-acquired pneumoniaantibiotic therapychild populationвнебольничная пневмонияантибиотикотерапиядетское население1.Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике: Евразийские клинические рекомендации / под ред. С. В. Яковлева, С. В. Сидоренко, В. В. Рафальского, Т. В. Спичак. М.: Издательство «Пре100 Принт», 2016 – 144 с.2.Геппе Н. А., Розинова Н. Н., Волков И. К., Козлова Л. В., Малахов А. Б., Манеров Ф. К., Мизерницкий Ю. Л., Внебольничная пневмония у детей. Клинические рекомендации. Москва: Оригинал-макет, 2015, 64 с.3.Ким С. С., Эффективные методы диагностики и лечения среднетяжелых внебольничных пневмоний у детей. Авт. дисс. канд. мед. наук, М, 2012, 24 с.4.Козлов Р.С., Кречикова О.И., Муравьев А.А. и другие (2013). Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (Papirus)., «Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний. Клиническая микробиология и антимикробная химиотерапия, 15 (4), 246-260».5.Заболеваемость детей в возрасте 0-14 лет по основным классам болезней в 2000-2020 гг. Статистические материалы МЗСР РФ.